Yuting Liu
- Molecular Biology top 5%
- Oncology top 5%
- Cancer Research top 5%
- Immunology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Topics
- Cancer Immunotherapy and Biomarkers (8 papers)RNA modifications and cancer (5 papers)Cancer-related molecular mechanisms research (5 papers)
- Partner nations
- ChinaUnited StatesGreece
In The Last Decade
Yuting Liu
79 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Molecular Biology 1.7k
- Oncology 698
- Cancer Research 629
- Immunology 435
- Pulmonary and Respiratory Medicine 307
Countries citing papers authored by Yuting Liu
This map shows the geographic impact of Yuting Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuting Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuting Liu more than expected).
Fields of papers citing papers by Yuting Liu
This network shows the impact of papers produced by Yuting Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuting Liu. The network helps show where Yuting Liu may publish in the future.
Co-authorship network of co-authors of Yuting Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Yuting Liu. A scholar is included among the top collaborators of Yuting Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuting Liu. Yuting Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 11 | |
| 4 | 4 | |
| 5 | 8 | |
| 6 | 12 | |
| 7 | 11 | |
| 8 | 1 | |
| 9 | 2 | |
| 10 | 7 | |
| 11 | 83 | |
| 12 | 37 | |
| 13 | 225 | |
| 14 | 1 | |
| 15 | 106 | |
| 16 | 49 | |
| 17 | 35 | |
| 18 | 86 | |
| 19 | Embryonic Development following Somatic Cell Nuclear Transfer Impeded by Persisting Histone Methylationbreakdown → | 356 |
| 20 | 99 |
About Yuting Liu
Yuting Liu is a scholar working on Cancer Research, Immunology and Oncology, having authored 83 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), RNA modifications and cancer (5 papers) and Cancer-related molecular mechanisms research (5 papers). The work is most often cited by research in Cancer Research (629 citations), Oncology (698 citations) and Molecular Biology (1.7k citations). Yuting Liu has collaborated with scholars based in China, United States and Greece. Frequent co-authors include Yi Zhang, Falong Lu, Shogo Matoba, David L. Rimm, Robert E. Dempski, Yan Xu, Kurt A. Schalper, Li Shen, Azusa Inoue and Kumiko A. Iwabuchi. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.